Rosson G B, Hazen-Martin D J, Biegel J A, Willingham M C, Garvin A J, Oswald B W, Wainwright L, Brownlee N A, Wright C F
Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston 29425, USA.
Mod Pathol. 1998 Dec;11(12):1228-37.
Malignant rhabdoid tumor (MRT) is a rare, enigmatic childhood cancer characterized by extreme aggressiveness and resistance to chemotherapy. To understand better the origin of the tumor and the mechanisms by which it develops and resists treatment, five cell lines were established from patients presenting with MRT (two renal and three extrarenal tumors). All of the cell lines display the light microscopic and ultrastructural features, as well as the variable immunohistochemical profile, characteristic of MRT. All are capable of forming tumors in nude mice. Three of the cell lines have detectable abnormalities of chromosome 22: one a t(22, 22) unbalanced translocation and two others a loss of heterozygosity of polymerase chain reaction-based microsatellite markers. Northern blot analysis showed that overexpression of the c-myc message was a consistent characteristic of the five MRTs evaluated. Although mutations of the p53 gene were not detectable by sequence analysis, all of the cell lines showed nuclear accumulation of the p53 protein by an immunocytochemical analysis in a minority of the cells. This result suggests that dysfunction in a p53-dependent apoptotic pathway might play a role in the multiple drug resistance phenotype of these tumors.
恶性横纹肌样瘤(MRT)是一种罕见的、难以捉摸的儿童癌症,其特征是具有极强的侵袭性且对化疗耐药。为了更好地了解该肿瘤的起源以及其发生和抵抗治疗的机制,从患有MRT的患者(2例肾肿瘤和3例肾外肿瘤)中建立了5种细胞系。所有细胞系均表现出MRT特有的光学显微镜和超微结构特征以及可变的免疫组织化学特征。所有细胞系都能够在裸鼠体内形成肿瘤。其中3种细胞系检测到22号染色体异常:一种是t(22, 22)不平衡易位,另外两种是基于聚合酶链反应的微卫星标记杂合性缺失。Northern印迹分析表明,c-myc信息的过表达是所评估的5种MRT的一致特征。虽然通过序列分析未检测到p53基因的突变,但通过免疫细胞化学分析,所有细胞系在少数细胞中均显示出p53蛋白的核内积聚。这一结果表明,p53依赖的凋亡途径功能障碍可能在这些肿瘤的多药耐药表型中起作用。